Junsheng Xue

Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer

Jian Li, Qingyu Yao, Junsheng Xue et al. · Acta Pharmacologica Sinica · 2017 · 37 citations · Full text

Medicine, Oncology, Pharmacology +16

Dexamethasone inhibits pancreatic tumor growth in preclinical models: Involvement of activating glucocorticoid receptor

Ye Yao, Qingyu Yao, Junsheng Xue et al. · Toxicology and Applied Pharmacology · 2020 · 31 citations

Medicine, Oncology, Pharmacology +13

Dopamine D1 receptor agonists inhibit lung metastasis of breast cancer reducing cancer stemness

Liang Yang, Ye Yao, Yong Ling et al. · European Journal of Pharmacology · 2019 · 30 citations

Medicine, Oncology, Pharmacology +17

Prediction of Human Pharmacokinetics and Clinical Effective Dose of SI–B001, an EGFR/HER3 Bi-specific Monoclonal Antibody

Junsheng Xue, Daming Kong, Ye Yao et al. · Journal of Pharmaceutical Sciences · 2020 · 23 citations

Pharmacy, Oncology, Pharmacokinetics +11

N-arylpiperazine-containing compound (C2): An enhancer of sunitinib in the treatment of pancreatic cancer, involving D1DR activation

Hong Su, Zixi Xue, Yaoyao Feng et al. · Toxicology and Applied Pharmacology · 2019 · 17 citations

Medicine, Medicinal Chemistry, Pharmacology +9